Teva launches 'Teva Rise' to harness global innovation and transform healthcare

Teva launches 'Teva Rise' to harness global innovation and transform healthcare

By: IPP Bureau

Last updated : November 21, 2025 4:15 pm



The initiative aims to connect startups and tech companies with its business units,


Teva Pharmaceutical Industries has unveiled a global innovation platform designed to fast-track the adoption of breakthrough technologies in healthcare. 

The initiative -- Teva Rise encompassing digital health and biotech -- aims to connect startups and tech companies with its business units, to tackle real-world pharmaceutical challenges while driving patient impact and accelerating Teva’s Pivot to Growth strategy. 

“This is an exciting first for Teva,” said Mark Sabag, EVP International Markets and global sponsor of Teva Rise. “By partnering with startups worldwide, we can unlock smarter solutions, channel tens of millions of dollars into innovation, and deliver meaningful value to patients everywhere.” 

The launch comes at a critical time as AI and digital transformation reshape drug development, manufacturing, and patient care. Teva Rise will give global innovators the chance to validate their solutions in real-world settings and scale across Teva’s international operations. 

The program kicks off with an open call for startups to address seven key challenges across R&D, manufacturing, supply chain, and commercial operations: 

The challenges include human-Predictive Platforms for Biologics: Scalable preclinical platforms like organ-on-chip or advanced cell culture; AI-Driven Clinical Trial Design: Machine learning models to optimize trials, reduce amendments, and improve recruitment and retention; Revolutionizing Patient Experience: Digital tools, smart devices, and behavioral science solutions for long-acting injectables. 

Selected startups will pilot their solutions with Teva and explore integration across the company’s global network. Over the coming years, Teva plans to invest tens of millions of dollars to accelerate these initiatives, building a competitive edge through technology. 

Richard Francis, Teva’s President and CEO, said, “Teva Rise is a powerful example of our Pivot to Growth strategy in action. By bringing together the best minds and technologies, we’re not just modernizing our operations—we’re transforming the future of healthcare for patients everywhere.”

Teva Pharmaceutical Industries R&D manufacturing supply chain

First Published : November 21, 2025 12:00 am